Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
Clinical trial NCT07517640 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07517640
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.